IL131881A0 - Sustained release formulation comprising octreotide - Google Patents
Sustained release formulation comprising octreotideInfo
- Publication number
- IL131881A0 IL131881A0 IL13188199A IL13188199A IL131881A0 IL 131881 A0 IL131881 A0 IL 131881A0 IL 13188199 A IL13188199 A IL 13188199A IL 13188199 A IL13188199 A IL 13188199A IL 131881 A0 IL131881 A0 IL 131881A0
- Authority
- IL
- Israel
- Prior art keywords
- octreotide
- sustained release
- release formulation
- formulation
- sustained
- Prior art date
Links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37702389A | 1989-07-07 | 1989-07-07 | |
US41134789A | 1989-09-22 | 1989-09-22 | |
IL9498399 | 1999-09-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL131881A0 true IL131881A0 (en) | 2001-03-19 |
Family
ID=27271456
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13188099A IL131880A0 (en) | 1989-07-07 | 1999-09-14 | Process for the production of micro particles using a water-in-oil emulsion and a sustained release formulation comprising said micro particles |
IL13188199A IL131881A0 (en) | 1989-07-07 | 1999-09-14 | Sustained release formulation comprising octreotide |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13188099A IL131880A0 (en) | 1989-07-07 | 1999-09-14 | Process for the production of micro particles using a water-in-oil emulsion and a sustained release formulation comprising said micro particles |
Country Status (1)
Country | Link |
---|---|
IL (2) | IL131880A0 (en) |
-
1999
- 1999-09-14 IL IL13188099A patent/IL131880A0/en unknown
- 1999-09-14 IL IL13188199A patent/IL131881A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL131880A0 (en) | 2001-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2230185B (en) | Sustained release pharmaceutical compositions | |
AU639947B2 (en) | Sustained release elements | |
CY1741A (en) | Sustained release matrix formulation | |
ZA894020B (en) | Controlled release pharmaceutical formulation | |
GB8908250D0 (en) | Formulations | |
GB9004950D0 (en) | Controlled release formulation | |
ZA904925B (en) | Sustained release pharmaceutical compositions | |
ZA899071B (en) | Sustained release diltiazem formulation | |
AU7942087A (en) | Sustained release formulations | |
AP9000232A0 (en) | Formulation | |
AP9000174A0 (en) | Antiparasitical formulations | |
GB8914791D0 (en) | Formulation | |
IL88148A0 (en) | Somatotropin sustained release formulations | |
IL131881A0 (en) | Sustained release formulation comprising octreotide | |
IE893777L (en) | Sustained release diltiazen formulation | |
AU663388B2 (en) | Sustained release formulations | |
GB8908838D0 (en) | Sustained release | |
GB8922061D0 (en) | Controlled release formulations | |
IE890121L (en) | New galenic formulations with programmed release | |
ZA898470B (en) | Sustained release preparations | |
IE871503L (en) | Sustained release formulations | |
IE880658L (en) | Sustained release compositions | |
IE862241L (en) | Injectable sustained release formulation | |
GB8922288D0 (en) | Formulations | |
GB8922917D0 (en) | Formulations |